Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Article
Guba, Markus, von Breitenbuch, Philipp, Steinbauer, Markus, Koehl, Gudrun, Flegel, Stefanie, Hornung, Matthias, Bruns, Christiane J., Zuelke, Carl, Farkas, Stefan, Anthuber, Matthias, Jauch, Karl-Walter and Geissler, Edward K. (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nature Medicine 8 (2), pp. 128-135.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Nature Medicine | ||||
| Publisher | NATURE AMERICA INC | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 8 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | pp. 128-135 | ||||
| Date | 2002 | ||||
| Date of publication | 19 Dec 2024 15:45 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie | ||||
| Identification Number |
| ||||
| Keywords | SIGNAL-TRANSDUCTION; LIVER METASTASES; CYCLOSPORINE-A; IN-VITRO; ANGIOGENESIS; MECHANISM; CANCER; CELLS; PROGRESSION; CARCINOMA; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 73189 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric